JUL 31, 2026 · PHASE 1 TRIAL
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity
ClinicalTrials.gov
Phase 1 trial in recruitment with no results posted; establishes only planned design and safety endpoints in adolescents with obesity.
Reported
Planned enrollment48
PhasePhase 1
Primary outcome measureAdverse Events (AEs), up to Week 28